Aspen Grove Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,904
Closed -$239K 201
2025
Q4
$239K Sell
1,904
-101
-5% -$12.9K 0.04% 170
2025
Q3
$269K Sell
2,005
-1,154
-37% -$151K 0.05% 161
2025
Q2
$430K Buy
3,159
+849
+37% +$112K 0.07% 130
2025
Q1
$306K Buy
2,310
+77
+3% +$9.8K 0.06% 157
2024
Q4
$253K Sell
2,233
-77
-3% -$8.9K 0.05% 164
2024
Q3
$263K Sell
2,310
-306
-12% -$33.6K 0.06% 161
2024
Q2
$272K Buy
2,616
+63
+2% +$6.68K 0.06% 159
2024
Q1
$290K Buy
+2,553
New +$293K 0.08% 152
2023
Q1
Sell
-3,329
Closed -$365K 153
2022
Q4
$365K Buy
+3,329
New +$345K 0.17% 97

Other funds holding ABT

Aspen Grove Capital's ABT Position: Q1 2026 in Review

Aspen Grove Capital sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,904 shares — an estimated $239K sold.

Aspen Grove Capital first reported a position in ABT in Q4 2022 and held it in 9 quarters. The position peaked at $430K in Q2 2025. 3,106 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Aspen Grove Capital reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Aspen Grove Capital sold 1,904 Abbott shares in Q1 2026, an estimated $239K.
  • Aspen Grove Capital first reported a position in Abbott in Q4 2022 and held it in 9 quarters.
  • Aspen Grove Capital's Abbott position peaked at $430K in Q2 2025.
  • 3,106 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Aspen Grove Capital's 13F filing for Q1 2026, filed 14 May 2026.